Table 2 Demographic data of all subjects.

From: Longitudinal corpus callosum microstructural decline in early-stage Parkinson’s disease in association with akinetic-rigid symptom severity

 

Baseline

24 month

Stats (t value, p value)

Age

61.6 ± 9.2

-

-

Gender

38 M, 23 F

-

-

Affected side (right/left/symmetrical)

33/26/2

-

-

Hoehn & Yahr

1.51 ± .5

1.75 ± .67

2.96, 0.004*

MoCA

27.1 ± 2.3

26.7 ± 3.16

0.54, 0.29

UPDRS-III total

20.8 ± 10.4

23.5 ± 14.0

1.66, 0.051

Akinetic rigid

10.7 ± 5.9

12.4 ± 7.7

2.31, 0.01*

Tremor

2.7 ± 2.4

2.7 ± 3.0

−1.78, 0.96

LEDD

-

250.6 ± 203.6

-

  1. MoCA Montreal Cognitive Assessment, UPDRS-III Total Unified Parkinson’s Disease Rating Scale part III total, Akinetic Rigid summed UPDRS scores for akinetic rigid symptoms, Tremor summed UPDRS scores for tremor symptoms, LEDD mean levodopa equivalent daily dose.
Back to article page